Adult Onset Secondary Enuresis
Links shared publicly online about this topic
Enuresis: eMedicine Pediatrics: Surgery
emedicine.medscape.com — “Overview: The word enuresis is derived from a Greek word that means to make water. In North America, the term is used to refer to wetting by night or day. Enuresis can be divided into primary enuresis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 9, 2010 at 1:09 pm By:
Medscape Pediatrics Pediatrics and Health Site
Alarm therapy a successful approach to enuresis in children. See the eMedicine article Enuresis. http://bit.ly/cQfpq6
Scottish Medicines Consortium Approves Zebinix - Once Daily Anti-Epileptic Treatment
medicalnewstoday.com — “Zebinix® (eslicarbazepine acetate), a treatment for epilepsy, has been accepted for restricted use in Scotland after a decision by The Scottish Medicines Consortium (SMC).1 Following the new c” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2010 at 1:52 pm By:
Scottish Medicines Consortium Approves Zebinix - Once Daily Anti-Epileptic Treatment: Zebinix® (eslicarbazepine ... http://mnt.to/f/3Mfx
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy
news-medical.net — “GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Commission has granted marketing authorisation for Trobalt as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.” View full resource at news-medical.net
Most Recently Shared on March 30, 2011 at 5:28 am By:
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy: GlaxoSmithKline and Valeant Phar... http://bit.ly/eYc0T1
GSK, Valeant receive European CHMP positive opinion for Trobalt
news-medical.net — “GlaxoSmithKline and Valeant Pharmaceuticals International, Inc. announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion, recommending marketing authorisation for Trobalt™ (retigabine) as an adjunctive treatment of partial onset seizures, with or without secondary generalisation in adults aged 18 years and above with epilepsy.” View full resource at news-medical.net
Most Recently Shared on January 21, 2011 at 6:07 pm By:
Epilepsy News: GSK, Valeant receive European CHMP positive opinion for Trobalt: GlaxoSmithKline and Valeant Phar... http://bit.ly/hHx0Fw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Medscape Pediatrics
Latest medical news, articles, and features from Medscape Pediatrics
-
Epilepsy OW
Organizing epilepsy resources shared by health experts, advocates, and organizations into WisdomCards.
-
News-Medical.Net
Medical News from Around the World
Advertisement
